News
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...
A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...
4h
Health and Me on MSNHIV Vaccine Research In South Africa Crumbles As U.S. Pulls FundingJust before a major HIV vaccine trial was to begin, U.S. funding cuts halted South Africa’s BRILLIANT project, threatening ...
One way to cope with cuts in HIV prevention funding is to continue to push to increase the number of people who self-test for HIV instead of getting tested at a clinic or hospital, experts at a series ...
Every 10 minutes, an adolescent girl or young woman is infected with HIV in South Africa. But a long-acting injection could ...
14h
The Print on MSNUNAIDS 2025 report warns of funding gaps in fight against HIV as India battles stigma, discriminationGlobal AIDS Update shows that 30% of surveyed Indians aged 15-49 reported facing stigma. Domestic violence, little autonomy ...
There are over 100,000 HIV+ Texans. Trump's 'big beautiful' bill would slash funding for federal HIV prevention, medications, ...
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed an access agreement with Pharmaceutical Company Gilead Sciences to procure lenacapavir, a ...
Severe cuts to international aid are disrupting lifesaving HIV services in vulnerable countries, with UNAIDS warning of millions of preventable infections and deaths if support isn’t restored.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results